Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Interest Coverage Ratio (2016 - 2017)

Heron Therapeutics (HRTX) has disclosed Interest Coverage Ratio for 3 consecutive years, with 59.79 as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Interest Coverage Ratio changed N/A year-over-year to 59.79, compared with a TTM value of 120.68 through Sep 2017, changed N/A, and an annual FY2025 reading of 0.26, up 86.17% over the prior year.
  • Interest Coverage Ratio was 59.79 for Q4 2016 at Heron Therapeutics, up from 60.59 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 23.61 in Q1 2012 and bottomed at 179.61 in Q1 2013.
  • Average Interest Coverage Ratio over 3 years is 79.56, with a median of 60.59 recorded in 2013.
  • Peak annual rise in Interest Coverage Ratio hit 660.75% in 2013, while the deepest fall reached 660.75% in 2013.
  • Year by year, Interest Coverage Ratio stood at 23.61 in 2012, then tumbled by 156.65% to 60.59 in 2013, then increased by 1.32% to 59.79 in 2016.
  • Business Quant data shows Interest Coverage Ratio for HRTX at 59.79 in Q4 2016, 60.59 in Q3 2013, and 74.19 in Q2 2013.